Neuroone Medical Technologies (NMTC) Depreciation and Depletion (2019 - 2026)

Neuroone Medical Technologies has disclosed Depreciation and Depletion across 8 years of filings, most recently posting $54450.0 for Q1 2026.

• Quarterly Depreciation and Depletion fell 9.33% year-over-year to $54450.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $234155.0 (down 0.65% YoY) and the FY2025 annual result came in at $239363.0, up 6.63% from the prior year.
• Depreciation and Depletion retreated to $54450.0 in Q1 2026, from $59945.0 in the prior quarter.
• Across five years, Depreciation and Depletion topped out at $61015.0 in Q2 2025 and bottomed at $22952.0 in Q1 2022.
• The 5-year median for Depreciation and Depletion is $55321.0 (2024), against an average of $48935.8.
• Year-over-year, Depreciation and Depletion surged 104.47% in 2023 and decreased 9.33% in 2026.
• Neuroone Medical Technologies' Depreciation and Depletion stood at $30310.0 in 2022, then surged by 75.12% to $53078.0 in 2023, then grew by 12.19% to $59548.0 in 2024, then rose by 0.67% to $59945.0 in 2025, then fell by 9.17% to $54450.0 in 2026.
• According to Business Quant data, Depreciation and Depletion over the past three periods registered $54450.0, $59945.0, and $58745.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.